Alliance for Cancer Gene Therapy announced the availability of grants up to $500,000 each for the 2019 grant cycle to fund investigators in the field of cancer gene therapy. The focus for the grants this year are scientists centering their work on solid, metastatic and childhood cancers. ACGT is known for its 18-year history of...
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
